SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | +33.3% | 132 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 132 | +109.5% | 0.00% | -100.0% |
Q1 2022 | $4,000 | -55.6% | 63 | -55.0% | 0.00% | 0.0% |
Q4 2021 | $9,000 | +200.0% | 140 | +169.2% | 0.00% | – |
Q3 2021 | $3,000 | -57.1% | 52 | -35.8% | 0.00% | -100.0% |
Q2 2021 | $7,000 | +133.3% | 81 | +118.9% | 0.00% | 0.0% |
Q1 2021 | $3,000 | – | 37 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |